In contrast to AKT1, STAT3 phosphorylation was not significantly changed after stimulation of LN18 cells with S1P despite a previously reported down-regulation of phosphorylated STAT3 in brain tumor stem cells after stimulation with the S1P analogue fingolimod [22]. The gene discussed is STAT3; the disease is brain neoplasm.